Cite
HARVARD Citation
Danese, S. et al. (n.d.). OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study. Journal of Crohn's and colitis. pp. S022-S024. [Online].